Your browser doesn't support javascript.
loading
Author Correction: Vaccination induces broadly neutralizing antibody precursors to HIV gp41.
Schiffner, Torben; Phung, Ivy; Ray, Rashmi; Irimia, Adriana; Tian, Ming; Swanson, Olivia; Lee, Jeong Hyun; Lee, Chang-Chun D; Marina-Zárate, Ester; Cho, So Yeon; Huang, Jiachen; Ozorowski, Gabriel; Skog, Patrick D; Serra, Andreia M; Rantalainen, Kimmo; Allen, Joel D; Baboo, Sabyasachi; Rodriguez, Oscar L; Himansu, Sunny; Zhou, Jianfu; Hurtado, Jonathan; Flynn, Claudia T; McKenney, Katherine; Havenar-Daughton, Colin; Saha, Swati; Shields, Kaitlyn; Schultze, Steven; Smith, Melissa L; Liang, Chi-Hui; Toy, Laura; Pecetta, Simone; Lin, Ying-Cing; Willis, Jordan R; Sesterhenn, Fabian; Kulp, Daniel W; Hu, Xiaozhen; Cottrell, Christopher A; Zhou, Xiaoya; Ruiz, Jennifer; Wang, Xuesong; Nair, Usha; Kirsch, Kathrin H; Cheng, Hwei-Ling; Davis, Jillian; Kalyuzhniy, Oleksandr; Liguori, Alessia; Diedrich, Jolene K; Ngo, Julia T; Lewis, Vanessa; Phelps, Nicole.
Afiliação
  • Schiffner T; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Phung I; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Ray R; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
  • Irimia A; Institute for Drug Discovery, Leipzig University Medical Faculty, Leipzig, Germany.
  • Tian M; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
  • Swanson O; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
  • Lee JH; The Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA.
  • Lee CD; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Marina-Zárate E; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
  • Cho SY; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Huang J; Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
  • Ozorowski G; Department of Genetics, Harvard Medical School, Boston, MA, USA.
  • Skog PD; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Serra AM; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Rantalainen K; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
  • Allen JD; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Baboo S; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Rodriguez OL; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
  • Himansu S; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Zhou J; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
  • Hurtado J; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Flynn CT; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
  • McKenney K; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
  • Havenar-Daughton C; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Saha S; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
  • Shields K; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Schultze S; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Smith ML; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
  • Liang CH; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Toy L; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Pecetta S; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
  • Lin YC; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Willis JR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Sesterhenn F; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Kulp DW; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
  • Hu X; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Cottrell CA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Zhou X; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
  • Ruiz J; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Wang X; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Nair U; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
  • Kirsch KH; School of Biological Sciences, University of Southampton, Southampton, UK.
  • Cheng HL; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.
  • Davis J; Department of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, KY, USA.
  • Kalyuzhniy O; Moderna, Inc., Cambridge, MA, USA.
  • Liguori A; Department of Computer Science, Dartmouth College, Hanover, NH, USA.
  • Diedrich JK; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Ngo JT; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Lewis V; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
  • Phelps N; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Nat Immunol ; 25(7): 1307, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38877179
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article